Limitations of electrocardiographic criteria of left ventricular hypertrophy in differentiation between hypertrophic cardiomyopathy, cardiac amyloidosis and Fabry disease

Introduction: Left ventricular hypertrophy (LVH) is a common pathology and should be differentiated using non-invasive and invasive methods. Electrocardiography (ECG) is the first choice method for the clinical evaluation of patients with LVH. Material and methods: A retrospective analysis of 77 pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Mateusz Tometczak (Author), Judyta Znamirowska (Author), Justyna Topa (Author), Patrycja Pastor (Author), Damian Waksmundzki (Author), Adam Grzebinoga (Author), Katarzyna Mizia-Stec (Author)
Format: Book
Published: Śląski Uniwersytet Medyczny w Katowicach, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4136a2dafb4c4d53b44c2a4482f2ddf0
042 |a dc 
100 1 0 |a Mateusz Tometczak  |e author 
700 1 0 |a Judyta Znamirowska  |e author 
700 1 0 |a Justyna Topa  |e author 
700 1 0 |a Patrycja Pastor   |e author 
700 1 0 |a Damian Waksmundzki  |e author 
700 1 0 |a Adam Grzebinoga  |e author 
700 1 0 |a Katarzyna Mizia-Stec  |e author 
245 0 0 |a Limitations of electrocardiographic criteria of left ventricular hypertrophy in differentiation between hypertrophic cardiomyopathy, cardiac amyloidosis and Fabry disease 
260 |b Śląski Uniwersytet Medyczny w Katowicach,   |c 2024-07-01T00:00:00Z. 
500 |a 10.18794/aams/182281 
500 |a 1734-025X 
520 |a Introduction: Left ventricular hypertrophy (LVH) is a common pathology and should be differentiated using non-invasive and invasive methods. Electrocardiography (ECG) is the first choice method for the clinical evaluation of patients with LVH. Material and methods: A retrospective analysis of 77 patients (pts; age: 54.1 ± 16.3; 50.6% men) with features of cardiac hypertrophy in an echocardiographic examination was performed. The population was divided into three subgroups: 60 pts with hypertrophic cardiomyopathy (HCM), 11 pts with cardiac amyloidosis (CA) and 6 pts with Fabry disease (FD). Multiple ECG records were evaluated and the presence and frequency of eight different LVH criteria were verified. Results: Among the study population LVH criteria were present in 67.6% pts with HCM, 53.8% pts with CA and 57.1% pts with FD. Analysis of the number of LVH ECG criteria revealed: none of LVH ECG criteria: in 32.4% pts of HCM, in 46.2% pts with CA, in 42.9% pts with FD; 1 LVH ECG criterion in 21.1% pts with HCM, 46.2% pts with CA and 14.3% pts with FD; 2-4 criteria in 33.8% pts with HCM, 7.7% pts with CA and 42.9% pts with FD; 5-7 criteria in 12.7% pts with HCM and no pts with CA or FD. No patient fulfilled the eight LVH ECG criteria. Conclusions: Electrocardiographic LVH criteria are not sensitive indicators of LVH. The mismatch between transthoracic echocardiography (TTE) and ECG findings is characteristic for CA and FD that may raise the suspicion of these diseases. The lack of LVH ECG criteria do not exclude these diagnoses. 
546 |a EN 
546 |a PL 
690 |a lvh ecg criteria 
690 |a hypertrophic cardiomyopathy 
690 |a amyloidosis 
690 |a fabry disease 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
690 |a Dentistry 
690 |a RK1-715 
655 7 |a article  |2 local 
786 0 |n Annales Academiae Medicae Silesiensis, Vol 78, Pp 173-178 (2024) 
787 0 |n https://annales.sum.edu.pl/Limitations-of-electrocardiographic-criteria-of-left-ventricular-hypertrophy-in-differentiation,182281,0,2.html 
787 0 |n https://doaj.org/toc/1734-025X 
856 4 1 |u https://doaj.org/article/4136a2dafb4c4d53b44c2a4482f2ddf0  |z Connect to this object online.